January 27, 2026

The Exam Room Is Listening Now

As AI quietly enters exam rooms, physicians report real relief—and real concerns about accuracy, trust, and control.

KFF Health News

January 23, 2026

US Leaves WHO Over Pandemic, Governance

The announcement describes a shift toward direct engagement with countries and organizations outside the World Health Organization.

Conexiant

January 20, 2026

IVF Babies and Allergy Risk: New Data

Cohort study of nearly 70,000 patients finds modest but statistically significant associations between assisted reproduction and asthma, allergic rhinitis, and atopic dermatitis

Conexiant

January 15, 2026

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Conexiant

January 08, 2026

Rapid Itch Relief Seen with Nemolizumab

Researchers examined early itch and sleep outcomes with interleukin-31 pathway inhibition in atopic dermatitis and prurigo nodularis in phase 3 trial analyses.

Conexiant

November 01, 2024

Are Antibiotics Needed for Pediatric Pneumonia?

Nearly one in five children diagnosed with pneumonia in outpatient settings did not receive antibiotics, according to a recent study in JAMA Network Open.

Conexiant

January 06, 2025

Does JIA Increase Arthritis Risk?

Explore how genetic overlap links juvenile idiopathic arthritis to adult rheumatic diseases.

Conexiant

November 01, 2024

Study: U.S. Faces Higher Drug Shortages

A recent study compared drug shortage risks between the U.S. and Canada, revealing that the U.S. experienced approximately a 40% higher drug shortage risk compared to Canada, with trends persisting both pre-pandemic and during COVID-19. The study highlighted that Canada's approach was associated with a lower shortage risk.

Conexiant

April 29, 2024

Nasal Neomycin May Offer Virus Protection 

A study funded by the Melinda and Bill Gates Foundation demonstrates the potential of intranasal neomycin to elicit broad-spectrum antiviral immunity in the upper respiratory tract, providing significant protection against upper respiratory infections in animal models and showing promising results in a pilot human study.

Conexiant